As an innovative foreign trade service provider driven by both technology transformation and foreign trade business, HiSiaddi has built a "1+2+3+4=1" service system and can supply vitamin B12 (cyanocobalamin) from multiple well-known original manufacturers. Possessing over a decade of market experience, HiSiaddi has accumulated extensive expertise resolving product compliance issues through technological transformation cooperation with manufacturers. Below is a case handled by HiSiaddi addressing compliance challenges for vitamin B12 (cyanocobalamin).
Contact HiSiaddi customer service for further inquiries regarding vitamin B12 (cyanocobalamin) compliance issues.
Client: NutriSanté SAS, FranceA mid-to-high-end French pharmaceutical and healthcare group specializing in prescription-grade nutritional APIs, premium dietary supplements and medical special medical food, supplying French pharmacies, top EU supermarkets and medical institutions. It enforces stringent full EU regulatory standards including EP 10.0, USP, cGMP, REACH and CLP, adopting zero-tolerance risk policies for incomplete compliance documentation, registration credentials, impurity control and labeling/packaging requirements, qualifying as a top-tier compliance-driven client.
The client was purchasing pharmaceutical-grade cyanocobalamin (vitamin B12) from China for the first time for new premium complex vitamin injections and sustained-release tablets. While sample testing passed after initial direct outreach to two domestic manufacturers, incomplete compliance files, absent REACH registration, non-compliant labeling and packaging, and incomplete impurity data triggered a pre-clearance risk assessment by French customs classifying the goods as "high compliance risk, prohibited from clearance", halting new product launch plans and exposing the client to massive breach-of-contract penalties and market losses. The client urgently commissioned HiSiaddi with a 30-day deadline to resolve all compliance defects, guarantee zero-barrier customs clearance and establish a long-term compliant supply system.
HiSiaddi’s compliance team intervened immediately, cross-referencing the latest EU regulations (REACH, EP, CLP, Directive 2002/46/EC) and the client’s internal quality standards to identify four fatal compliance defects prioritized for inspection by EU customs and pharmaceutical regulators:
1.
Missing REACH Registration (Primary Barrier)Cyanocobalamin is a Substance of Very High Concern (SVHC) controlled under EU REACH regulations. Imports exceeding 1 ton per year require formal REACH registration; otherwise market entry is prohibited. The two manufacturers contacted by the client only completed pre-registration without formal registration certificates, Only Representative (OR) authorization or complete registration dossiers (technical files + toxicology data), rendering imports illegal with 100% detention risk at customs.
2.
3.
Incomplete Pharmacopoeia Compliance Documentation (Failed Dual EP/USP Standards)The client mandates simultaneous compliance with EP 10.0 and USP-NF dual standards, requiring CEP (European Pharmacopoeia Certificate of Suitability), DMF filing numbers, cGMP audit reports and GLP laboratory test reports. The manufacturers could only provide self-prepared COAs lacking CEP, DMF and third-party authoritative test reports, with incomplete impurity data (free cyanide, heavy metals, microorganisms) preventing EU pharmaceutical registration filing.
4.
5.
Label & Packaging Violations of CLP Regulations (Direct Risk of Shipment Return)EU CLP Regulation (EC 1272/2008) mandates API labels display UN number, hazard classification, precautionary statements, ingredient content, batch number, manufacturer information and bilingual EU language labeling (French/English/German). The manufacturers supplied monolingual Chinese labels lacking UN numbers, hazard pictograms and safety warnings, packaged in standard woven bags without light-proof hermetic sealing, moisture resistance or leak-proof treatment – violating pharmaceutical-grade packaging standards and triggering direct customs return of shipments.
6.
7.
Missing Traceability & Batch Consistency Documentation (Broken Supply Chain Compliance)EU regulations demand full traceability records for every batch covering fermentation strains, raw auxiliary materials, production logs, testing data, warehousing and transportation, with inter-batch indicator variation limited to ≤1%. The manufacturers could not supply strain identification reports, auxiliary material COAs, warehousing temperature/humidity logs or transport temperature control records, breaking the traceability chain and failing the client’s internal quality audits.
8.
HiSiaddi assembled a dedicated cross-functional team of regulatory specialists, technical engineers and customs clearance officers, implementing a five-dimensional phased solution (credential supplementation, documentation restructuring, packaging upgrade, registration agency service and compliance training) with fixed deadlines to achieve 100% compliance against all requirements.
Compliant Manufacturer Screening: The two unqualified manufacturers were eliminated, and three domestic manufacturers holding formal REACH registration, CEP and DMF triple certifications were shortlisted (Zhejiang Medicine, North China Pharmaceutical, Shijiazhuang Pharmaceutical Huarong). Zhejiang Medicine was ultimately selected with valid REACH registration number REACH-REG-XXXXXX and an EU local compliance institution acting as its Only Representative.Complete Registration Dossier Retrieval: Coordinated the manufacturer to supply formal REACH registration certificates, OR authorization letters, full technical dossiers (16 toxicology datasets + exposure assessments + risk control measures) and SVHC compliance statements with official EU-stamped English originals for submission to French customs and ECHA filing.Locked Annual Registration Volume: Assisted the client with EU importer registration and signing of an annual procurement agreement (5 tons/year) to satisfy REACH registration tonnage thresholds, permanently resolving market access credential barriers.
Supplementation of Authoritative Credentials: Coordinated the manufacturer to supply EDQM-issued CEP certificates (EP 10.0 certified), FDA DMF filing numbers, NMPA and EU-audited cGMP certificates and GLP laboratory credentials, all verifiable via EDQM and FDA official websites.Full-Scope Third-Party Testing: Commissioned Eurofins, an EU-accredited third-party laboratory, to conduct full testing aligned with dual EP 10.0 + USP-NF standards (assay, purity, free cyanide, heavy metals, microorganisms, dissolution rates, stability), issuing English test reports and compliance statements with ppm-level precision impurity data fully meeting client requirements.Batch Consistency Verification: Retrieved three months of production logs and testing data from the manufacturer to verify inter-batch assay deviation ≤0.5% and impurity fluctuation ≤1ppm, issuing a batch consistency report guaranteeing supply chain stability.
Bilingual Label Redesign: CLP-compliant French/English dual-language labels were redesigned containing product name Cyanocobalamin, assay ≥99.5%, UN number UN 3077, hazard class (Class 9 dangerous goods), precautionary statements (avoid skin/eye contact), batch number, production date, expiry date, manufacturer and EU importer information, plus EU CE marking.Custom Pharmaceutical-Grade Packaging: Dual-layer packaging was specified: inner light-proof hermetic pharmaceutical aluminum foil bags, outer moisture-proof explosion-resistant cartons meeting IATA standards with leak-proof liners, desiccants and temperature/humidity indicator cards for full light, moisture and contamination protection during transit, aligned with EU pharmaceutical API packaging standards.Packaging Compliance Documentation: Issued CLP packaging compliance statements and UN packaging certification documents for filing with French customs to eliminate shipment return risks from packaging violations.
Consolidation of Full-Chain Traceability Dossiers: Assisted the manufacturer in compiling complete traceability archives including strain identification reports, auxiliary material COAs, production batch records, equipment validation reports, warehousing temperature/humidity logs, GPS transport temperature control data and customs clearance documents, with unique batch numbers enabling full traceability "from strain to client warehouse".Client Internal Compliance Training: Delivered specialized EU regulatory training (REACH, EP, CLP, traceability requirements) for the client’s quality and procurement teams, covering document review key points, customs audit priorities and common compliance violation risks to enable error-free independent review for future orders.Tripartite Compliance Agreement Execution: Signed a three-way compliance agreement between the manufacturer, HiSiaddi and the client clarifying compliance responsibilities, documentation standards and quality compensation clauses, establishing a monthly compliance audit mechanism for long-term risk prevention.
HiSiaddi adhered strictly to the implementation timeline:
· Days 1–5: Manufacturer screening and credential retrieval
· Days 6–15: REACH registration, CEP/DMF documentation and third-party test report completion
· Days 16–25: Bilingual label design, custom pharmaceutical packaging production and traceability dossier consolidation
· Days 26–30: Final document review, customs filing and shipment dispatchAll compliance documentation passed one-time review by French customs and pharmaceutical regulators without inquiries, inspections or detentions, enabling smooth goods clearance and warehousing.
Laboratory testing conducted by the client yielded: cyanocobalamin assay 99.6%, free cyanide 18ppm, heavy metals ≤1ppm, no microbial detection – all indicators surpassing EP/USP standards. Accelerated stability testing (40°C/RH75%) over 60 days showed no discoloration and potency decline limited to 1.5%, with inter-batch consistency deviation ≤0.4%, fully meeting production requirements for premium injections and sustained-release tablets.
The client formally awarded HiSiaddi exclusive status as its sole Chinese compliance procurement agent, formalizing the following terms:
· All cyanocobalamin procurement must be processed via HiSiaddi, locking in Zhejiang Medicine VB12-EP995/EP997 dual variants.
· Fixed quarterly repeat orders of 1.5 tons, stabilizing annual procurement volume at 6 tons.
· Entrusted HiSiaddi with compliance procurement for all subsequent premium raw materials (methylcobalamin, folic acid, vitamin D3), replicating this compliance resolution framework.
Successful compliance rectification saved the client approximately EUR 500,000 in potential customs fines and EUR 3,000,000 in lost revenue from delayed new product launches, alongside reputational brand damage. Standardized compliance workflows were established to eliminate repetitive document review for future procurement, drastically boosting supply chain efficiency and sustaining stable supply of premium products.
For overseas mid-to-high-end clients purchasing vitamin B12 (cyanocobalamin), compliance constitutes the first and highest threshold of procurement. Overlapping layers of EU regulations including REACH, EP, CLP and traceability impose rigorous audits with extremely high penalties for violations. Conventional manufacturers and general foreign trade firms lack professional regulatory expertise, frequently trapping clients in cycles of incomplete documentation, customs detention and suspended business operations.
With over 10 years of specialized experience in pharmaceutical chemical compliance, an in-house EU regulatory expert team, access to leading manufacturer resources and full end-to-end customs clearance capabilities, HiSiaddi connects the full compliance chain covering registration, documentation, packaging, traceability and training to precisely resolve four core compliance pain points. Beyond facilitating short-term customs clearance, the company builds permanent compliant supply systems. For top-tier mid-to-high-end clients, professional compliance services deliver greater core value than product quality itself – this is the critical factor enabling HiSiaddi to establish deep partnerships with premium clients across France, Germany, the Netherlands and other EU nations, emerging as a benchmark for compliant Chinese premium raw material exports.
Contact HiSiaddi customer service for further inquiries regarding vitamin B12 (cyanocobalamin) compliance issues.
+86-13120989737 
info@hisiaddi.com 
English
